Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04646395
Title Study of Acalabrutinib and Tafasitamab in MZL Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors International Extranodal Lymphoma Study Group (IELSG)
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA | CHE | AUT

Facility Status City State Zip Country Details
University of Wien Wien 1190 Austria Details
ASST Spedali Civili di Brescia Brescia Italy Details
Fondazione IRCCS - Istituto Nazionale dei Tumori Milano Italy Details
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico Milano Italy Details
Ospedale Maggiore della Carità Novara Italy Details
AUSL Ravenna U.O. Ematologia Ravenna 48121 Italy Details
Azienda Ospedaliera - IRCCS - Arcispedale Santa Maria Nuova Reggio Emilia Italy Details
Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi Varese Italy Details
Oncology Institute of Southern Switzerland Bellinzona 6500 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field